(redirected from cytoreductive therapy)
Also found in: Medical.
Related to cytoreductive therapy: Anagrelide, tumor debulking


n. destrucción de celulas, gen. células cancerosas clonos por medio de quimioterapia.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
(1,2,6,8,9) Among patients with either hematologic or solid tumors, bulky disease and tumors that are highly sensitive to cytoreductive therapy pose the greatest risk of TLS.
KEYTRUDA is not recommended for the treatment of patients with PMBCL who require urgent cytoreductive therapy. With this indication, KEYTRUDA becomes the first anti-PD-1 therapy to be approved for the treatment of PMBCL, a type of non-Hodgkin lymphoma.
In addition, cytoreductive therapy was recommended for high-risk ET patients.[7] Except for case 3, who refused the procedure, the others were administered contemporary cytoreduction (HU or IFN-a) and antithrombotic therapy, which revealed favorable long-term outcomes.
In our case, a lack of awareness of this phenomenon led to several changes in the antimicrobial regimen and delayed the initiation of appropriate cytoreductive therapy.
Surgery with cytoreductive therapy and intraperitoneal chemotherapy is the approach with better outcomes described.
Cytoreductive therapy is not recommended as initial treatment.
The patient had no previous incidents of thrombosis or hemorrhage; however as she was older than 65 years cytoreductive therapy with hydroxyurea (HU) has been introduced.